Mitochondrial mutations and human disease

Environmental and Molecular Mutagenesis

Volumn 25, Issue 2 S, 1995, Pages 30-37

  Grossman, Lawrence I ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aging; mitochondrial DNA; mutation; neuromuscular diseases

Indexed keywords

MITOCHONDRIAL DNA;

GENETIC DISORDER; HUMAN; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; MUTATION; REVIEW;

AGING; ANIMAL; BASE SEQUENCE; DNA, MITOCHONDRIAL; ENVIRONMENTAL POLLUTANTS; GENETIC DISEASES, INBORN; HUMAN; MOLECULAR SEQUENCE DATA; MUTAGENS; MUTATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029011850     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.2850250607     Document Type: Article

References (95)

1. Measuring the effects of nucleoside analogs on mitochondrial DNA content using the polymerase chain reaction
2. Review of genetic investigations into the aging processes of Drosophila
3. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine‐induced myopathy
4. Rapid segregation of heteroplasmic bovine mitochondria
5. Biogenesis and assembly of the mitochondrial respiratory chain: Structural, genetic and pathological aspects
6. Mitochondrial DNA is a major cellular target for a dihydrodiolepoxide derivative of benzo[a]pyrene
7. Interaction of benzo[a]pyrene and its dihydrodiol‐epoxide derivative with nuclear and mitochondrial DNA in C3H10T 1/2 cell cultures
8. Longevity in fish: Some ecological and evolutionary considerations
9. Abnormal RNA processing associated with a novel transfer RNA mutation in mitochondrial DNA—a potential disease mechanism
10. Evidence for and against the causal involvement of mitochondrial DNA mutation in mammalian ageing
11. Rapid shift in genotype of human mitochondrial DNA in a family with Leber hereditary optic neuropathy
12. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged‐red fibers (MERRF
13. Molecular basis of mitochondrial DNA disease
14. Leber's hereditary optic neuropathy—A model for mitochondrial neurodegenerative diseases
15. The mitochondrial genome of animals
16. The comparative biology of longevity and lifetime energetics
17. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts
18. MELAS—clinical features, biochemistry, and molecular genetics
19. Influence of the energetic pattern of mitochondria in cell ageing
20. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease
21. Detection of a specific mitochondrial DNA deletion in tissues of older humans
22. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues
23. Zidovudine‐induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage
24. Role of oxidative stress in Drosophila aging
25. Maternal inheritance of human mitochondrial DNA
26. Leu(UUR) gene associated with the MELAS subgroup in mitochondrial encephalomyopathies
27. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke‐like episodes (MELAS
28. Leu(UUR) gene in a family with mitochondrial myopathy
29. Paternal inheritance of mitochondrial DNA in mice
30. Organ distribution of mutant mitochondrial transfer RNA(leu(UUR)) gene in a MELAS patient
31. Aging: A theory based on free radical and radiation chemistry
32. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies
33. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
34. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy
35. An example of Leber hereditary optic neuropathy not involving a mutation in the mitochondrial ND4 gene
36. Leber hereditary optic neuropathy: Involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation
37. Mitochondrial encephalomyopathies due to electron transport chain defects
38. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the transfer RNA(Leu)(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes
39. Replacement of bovine mitochondrial DNA by a sequence variant within one generation
40. Unequal partitioning of bovine mitochondrial genotypes among siblings
41. Aging and resistance to oxidative damage in Caenorhabditis elegans.
42. 2 production in pigeon heart mitochondria
43. Dietary restriction attenuates age‐related increases in rat skeletal muscle antioxidant enzyme activities
44. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology
45. In vivo and in vitro evidence for slipped mispairing in mammalian mitochondria
46. Food restriction in rodents: An evaluation of its role in the study of aging
47. An integrated theory of aging as the result of mitochondrial DNA mutation in differentiated cells
48. Theoretical and experimental support for an ‘oxygen radical‐mitochondrial injury’ hypothesis of cell aging
49. Recombination via flanking direct repeats is a major cause of large‐scale deletions of human mitochondrial DNA
50. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns‐Sayre syndrome
51. Mitochondrial diseases: Toward a rational classification
52. Leu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): Genetic, biochemical, and morphological correlations in skeletal muscle
53. Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions
54. Leu(UUR) gene an etiologic hot spot?
55. A mitochondrial tRNA anticodon swap associated with a muscle disease
56. A new point mutation associated with mitochondrial encephalomyopathy
57. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease—an age‐related alteration
58. The point mutation of mitochondrial DNA characteristic for MERRF disease is found also in healthy people of different ages
59. Formation of benzo[alpha]pyrene metabolites and DNA adducts catalyzed by a rat liver mitochondrial monooxygenase system
60. Different copy numbers of apparently identically deleted mitochondrial DNA in tissues from a patient with Kearns‐Sayre syndrome detected by PCR
61. tRNA punctuation model of RNA processing in human mitochondria
62. Extremely high levels of mutant mtDNAs co‐localize with cytochrome c oxidase‐negative ragged‐red fibers in patients harboring a point mutation at nt 3243
63. Kearns‐Sayre syndrome—different amounts of deleted mitochondrial DNA are present in several autoptic tissues
64. Do mitochondrial DNA fragments promote cancer and aging?
65. Clinical syndromes associated with ragged red fibers
66. A direct repeat is a hotspot for large‐scale deletion of human mitochondrial DNA
67. Distribution of wild‐type and common deletion forms of mtDNA in normal and respiration‐deficient muscle fibers from patients with mitochondrial myopathy
68. Widespread tissue distribution of mitochondrial DNA deletions in Kearns‐Sayre syndrome
69. Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies
70. Spontaneous Kearns‐Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: A slip‐replication model and metabolic therapy
71. Subacute necrotizing encephalopathy—oxidative phosphorylation defects and the ATPase 6 point mutation
72. Tissue distribution of mutant mitochondrial DNA in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke‐like episodes (MELAS
73. Clinical features associated with the A ‐ G transition at nucleotide 8344 of mtDNA (MERRF mutation
74. leuUUR gene associated with maternally inherited cardiomyopathy
75. Accumulation of deletions in human mitochondrial DNA during normal aging—analysis by quantitative PCR
76. HIV or zidovudine myopathy
77. Studies on the inhibition of mitochondrial DNA replication by 3′‐azido‐3′‐deoxythymidine and other dideoxynucleoside analogs which inhibit HIV‐1 replication
78. Aging, cytochrome oxidase activity, and hydrogen peroxide release by mitochondria
79. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain
80. Benzo[a]pyrene differentially alters mitochondrial and nuclear DNA synthesis in primary hepatocyte cultures
81. (3243)(Leu) point mutation of mitochondrial DNA in MELAS patients and its effects on mitochondrial transcription
82. Mitochondrial DNA transfer RNA mutation LEU(UUR) A ‐ G‐3260—a second family with myopathy and cardiomyopathy
83. Heteroplasmic mtDNA mutation (T ‐ G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high
84. Diseases of the mitochondrial DNA
85. Mitochondrial genetics: A paradigm for aging and degenerative diseases
86. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy
87. Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease
88. Mitochondrial respiratory chain inhibitors induce apoptosis
89. Liver mitochondria respiratory functions declined with age
90. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy
91. Deletions of mitochondrial DNA in Kearns‐Sayre syndrome
92. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies
93. Nucleus‐driven multiple large‐scale deletions of the human mitochondrial genome: A new autosomal dominant disease
94. Maternally inherited myopathy and cardiomyopathy—association with mutation in mitochondrial DNA transfer‐RNA‐Leu(UUR